These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 18927121

  • 21. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB, Mestiri S, Chahed K, Bouaouina N, Gabbouj S, Jalbout M, Chouchane L.
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [Abstract] [Full Text] [Related]

  • 22. Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes.
    Fatar M, Stroick M, Steffens M, Senn E, Reuter B, Bukow S, Griebe M, Alonso A, Lichtner P, Bugert P, Meitinger T, Wienker TF, Hennerici MG.
    Cerebrovasc Dis; 2008 Sep; 26(2):113-9. PubMed ID: 18560213
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases.
    Spink C, Stege G, Tenbrock K, Harendza S.
    Nephrol Dial Transplant; 2013 Nov; 28(11):2800-5. PubMed ID: 23975748
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Strong and persistent microbial and inflammatory stimuli overcome the genetic predisposition to higher matrix metalloproteinase-1 (MMP-1) expression: a mechanistic explanation for the lack of association of MMP1-1607 single-nucleotide polymorphism genotypes with MMP-1 expression in chronic periodontitis lesions.
    Repeke CE, Trombone AP, Ferreira SB, Cardoso CR, Silveira EM, Martins W, Trevilatto PC, Silva JS, Campanelli AP, Garlet GP.
    J Clin Periodontol; 2009 Sep; 36(9):726-38. PubMed ID: 19659894
    [Abstract] [Full Text] [Related]

  • 27. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I.
    Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
    [Abstract] [Full Text] [Related]

  • 28. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
    Hata H, Kitamura T, Higashino F, Hida K, Yoshida K, Ohiro Y, Totsuka Y, Kitagawa Y, Shindoh M.
    Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin-converting enzyme gene polymorphism and the progression rate of focal segmental glomerulosclerosis in Iranian children.
    Gheissari A, Salehi M, Dastjerdi SB, Jahangiri M, Hooman N, Otookesh H, Merikhipour A, Ajir A, Foroughmand A, Khatami S, Shahidi S, Atapour A, Seirafian S, Naeini AE.
    Nephrology (Carlton); 2008 Dec; 13(8):708-11. PubMed ID: 19076285
    [Abstract] [Full Text] [Related]

  • 30. Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.
    Rodríguez-Pla A, Beaty TH, Savino PJ, Eagle RC, Seo P, Soloski MJ.
    Arthritis Rheum; 2008 Jun; 58(6):1849-53. PubMed ID: 18512818
    [Abstract] [Full Text] [Related]

  • 31. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
    Wei JC, Lee HS, Chen WC, Shiu LJ, Yang SF, Wong RH.
    Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
    [Abstract] [Full Text] [Related]

  • 32. Microarray analysis of focal segmental glomerulosclerosis.
    Schwab K, Witte DP, Aronow BJ, Devarajan P, Potter SS, Patterson LT.
    Am J Nephrol; 2004 Nov; 24(4):438-47. PubMed ID: 15308877
    [Abstract] [Full Text] [Related]

  • 33. [Glomerulonephritis with minimal changes and focal glomerulosclerosis in the adult. Analysis of 20 cases].
    Martín R, Alvarez C, Roque H, Paz RA.
    Medicina (B Aires); 1978 Nov; 38(6 Pt 1):621-8. PubMed ID: 750853
    [No Abstract] [Full Text] [Related]

  • 34. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.
    Navarro-Muñoz M, Ibernon M, Pérez V, Ara J, Espinal A, López D, Bonet J, Romero R.
    Nephrol Dial Transplant; 2011 Dec; 26(12):3914-23. PubMed ID: 21414970
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
    Varadi V, Brendle A, Grzybowska E, Johansson R, Enquist K, Butkiewicz D, Pamula-Pilat J, Pekala W, Hemminki K, Lenner P, Försti A.
    Cancer Genet Cytogenet; 2009 Apr 15; 190(2):71-4. PubMed ID: 19380022
    [Abstract] [Full Text] [Related]

  • 38. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
    Danilewicz M, Wagrowska-Danilewicz M.
    Przegl Lek; 1996 Apr 15; 53(7):529-33. PubMed ID: 8975287
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Promoter polymorphism in the MS4A2 gene and asthma in the Indian population.
    Sharma S, Ghosh B.
    Int Arch Allergy Immunol; 2009 Apr 15; 149(3):208-18. PubMed ID: 19218813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.